CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 60 enrolled
Drug / intervention
Classic Egg Group +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01256320
NCT01256320N/ACompleted
CompareCT.gov

The Impact of Egg Consumption on Indices of Vascular Health in Individuals With Peripheral Arterial Disease

University of Manitoba·interventional·Posted Dec 8, 2010·Updated May 4, 2017

In Brief

A clinical study evaluating Classic Egg Group and Omega 3 Egg Group for Peripheral Arterial Disease. Completed, enrolled 60 participants across 1 site.

Detailed Summary

The current research study has the potential to generate data that would provide solid clinical endpoints as to the impact of including eggs in a regular diet in individuals with peripheral arterial disease. Any one of three potential outcomes may be observed as a result of this study, and they are predicted as follows: 1) Egg consumption does not lead to a deterioration of indices of cardiovascular health; 2) Egg consumption improves indices of cardiovascular health; 3) Egg consumption worsens the indices of cardiovascular health.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPeripheral Arterial Disease
CountriesCanada
Collaborators--

Timeline

N/ACompletedFinished
20102011201220132014201520162017201820192020202120222023202420252026
First PostedDec 8, 2010
Enrollment StartJun 1, 2010
Primary CompletionDec 1, 2012
Study CompletionFeb 1, 2013
TodayJul 2, 2026
Enrollment to primary: 2.5 yearsPosted 15.6 years ago

Interventions

Classic Egg Groupother

consumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial classic eggs

Omega 3 Egg Groupother

consumption of 6 eggs/week (1 egg/day for 6 days with 1 day rest) of commercial Omega-3 eggs